The updates include new recommendations for COVID-19 and pneumococcal vaccines.
A new year means it’s time for new vaccine schedules for children, adolescents, and adults. At their October 2022 meeting, members of the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to approve the 2023 editions of the Recommended Child and Adolescent Immunization Schedule. At press time, the CDC director has adopted the recommendations, and they will become official once published in the Morbidity and Mortality Weekly Report.1
The following tables have been created using the recommended immunization schedules for 2023. As always, visit cdc.gov/vaccines/acip for the most up-to-date information.
Reference
1. Advisory Committee on Immunization Practices (ACIP). CDC. Updated November 23, 2022. Accessed November 30, 2022. https://www.cdc.gov/vaccines/acip/index.html
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
April 9th 2024Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.